touchENDOCRINOLOGY publishes two peer-reviewed, free-to-access journals, that aim to provide insightful and topical articles relevant to the day-to-day practice of busy physicians. View our latest and archive content below.
More information about our journals along with how to submit your work can be found here.
Carbohydrate-rich Meals Have no Impact on Post-prandial Lipid Parameters in Indians with Subclinical and Overt Primary Hypothyroidism
European Endocrinology. 2020;16(2):161–6 DOI: https://doi.org/10.17925/EE.2020.16.2.156
The estimation of lipid parameters has traditionally been carried out in the fasting state, without definitive evidence to suggest that this is superior to assessing them in the post-prandial period in terms of predicting metabolic outcomes and cardiovascular risk.1 Post-prandial lipoprotein metabolism is believed to play a role in the development of atherosclerosis.2 Post-prandial dyslipidaemia may be […]
Bilateral Adrenocortical Carcinoma Presenting as Acute Adrenal Insufficiency
European Endocrinology. 2020;16(2):172–4 DOI: https://doi.org/10.17925/EE.2020.16.2.172
Adrenocortical carcinoma (ACC) is a rare malignancy, and presentation as bilateral adrenal masses and acute adrenal insufficiency is even rarer. Due to the relative commonality of other causes for bilateral adrenal masses, such as metastases or infiltrative diseases, they take precedence while considering differential diagnoses. We present the case of a gentleman who presented with […]
The Prevalence and Predictors of Non-alcoholic Fatty Liver Disease in Morbidly Obese Women – A Cross-sectional Study from Southern India
European Endocrinology. 2020;16(2):152–5 DOI: https://doi.org/10.17925/EE.2020.16.2.152
The prevalence of obesity is rapidly increasing across the world. In India, about 12.6% women and 9.3% men are obese, amounting to more than a 100 million population.1 Obesity, which was earlier considered to be a growing problem only in metropolitan cities, is now noted to be just as prevalent in smaller semi-urban towns.2 It is not […]
Relationship Between Statin-associated Muscle Symptoms, Serum Vitamin D and Low-density Lipoprotein Cholesterol – A Cross-sectional Study
European Endocrinology. 2020;16(2):137–42 DOI: https://doi.org/10.17925/EE.2020.16.2.137
Statin-associated muscle symptoms (SAMS) may lead to medication non-adherence among statin users. SAMS include myalgia, myositis and rhabdomyolysis (rarely seen).1 According to a recent study conducted in India, about 22% of statin users are affected by SAMS.2 Many studies have been conducted to establish a correlation between SAMS and levels of vitamin D and creatine phosphokinase (CPK; […]
A Review of the Pathology, Diagnosis and Management of Colloid Goitre
European Endocrinology. 2020;16(2):131–5 DOI: https://doi.org/10.17925/EE.2020.16.2.131
Colloid goitre is defined as thyroid enlargement without accompanying disturbance in thyroid function. This is a common pathology, frequently found in clinical practice during a physical or ultrasound examination. Colloid goitre has been classified as nontoxic goitre according to the updated International Classification of Diseases (Table 1).1 Colloid goitre is also known as endemic goitre, simple […]
Anticancer Medications and Sodium Dysmetabolism
European Endocrinology. 2020;16(2):122–30 DOI: https://doi.org/10.17925/EE.2020.16.2.122
Recent advances have bolstered the anticancer therapeutic armamentarium. However, despite the enhanced efficacy and better survival offered by these newer agents, side effects remain a source of concern.1 Gastrointestinal side effects, organ toxicities and dyselectrolytaemias are critical adverse consequences. Among these, dyselectrolytaemias are multifactorial and need to be monitored and managed appropriately.1 In this review, we aim […]
Can Serum Cortisol Be Used To Monitor Patients With COVID-19?
US Endocrinology. 2020;16(2):Online ahead of journal publication
Management of patients with severe COVID-19 remains a challenge for physicians. In severe cases of COVID-19, a hyperactive innate immune response characterized by high serum levels of proinflammatory markers, known as a ‘cytokine storm’, is characteristically present. The cytokine storm induces fulminant pulmonary inflammation known as acute respiratory distress syndrome, and subsequently systemic inflammation, which […]
Cardiorenal Syndrome in Type 2 Diabetes Mellitus – Rational Use of Sodium–glucose Cotransporter-2 Inhibitors
European Endocrinology. 2020;16(2):113–21 DOI: https://doi.org/10.17925/EE.2020.16.2.113
The International Diabetes Federation (IDF) estimates that 463 million people worldwide suffer from diabetes, 90% of whom have type 2 diabetes mellitus (T2DM), and expects the total healthcare expenditure on diabetes to reach US$ 845 billion by 2045 from US$ 760 billion in 2019.1 People with diabetes comprise 9.3% of the world’s adult population, and the […]
Short-term Hydroxychloroquine in COVID-19 Infection in People With or Without Metabolic Syndrome – Clearing Safety Issues and Good Clinical Practice
European Endocrinology. 2020;16(2):109–12 DOI: https://doi.org/10.17925/EE.2020.16.2.109
Hydroxychloroquine has been in clinical use for decades, being extensively used by rheumatologists across the globe for different autoimmune disorders (rheumatoid arthritis, lupus and Sjögren‘s syndrome, among others), across all age groups and including during pregnancy. Novel coronavirus disease (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a pandemic sweeping […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!